George M. Garibaldi
Basel, BS 4051, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Qualitative validation of TnED©, an electronic instrument capturing pain dimensions in patients with trigeminal neuralgia.
Journal: Journal of oral & facial pain and headache
Published: September 08, 2025
Exploratory analysis of the relationship between striatal connectivity and apathy during phosphodiesterase 10 inhibition in schizophrenia: findings from a randomized crossover trial.
Journal: BMC medicine
Published: August 08, 2024
Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme.
Journal: The lancet. Psychiatry
Published: February 29, 2016
Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies.
Journal: Biological psychiatry
Published: February 25, 2016
Psychometric evaluation of the Work Readiness Questionnaire in schizophrenia.
Journal: CNS spectrums
Published: October 02, 2014
Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms.
Journal: Schizophrenia research
Published: July 23, 2014
Quantifying motivational deficits and apathy: a review of the literature.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: June 29, 2014
Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders.
Journal: Journal of affective disorders
Published: June 20, 2014
Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials.
Journal: Journal of geriatric psychiatry and neurology
Published: June 16, 2014
Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study.
Journal: JAMA psychiatry
Published: April 04, 2014
Reliability, validity and ability to detect change of the PANSS negative symptom factor score in outpatients with schizophrenia on select antipsychotics and with prominent negative or disorganized thought symptoms.
Journal: Psychiatry research
Published: November 22, 2013
A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: July 29, 2013
Last Updated: 09/26/2026